Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 01.01.1998 (9631
dage). |
Ingen historik.
Branche | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
Sidst opdateret den 22.12.2007 og
angivet som gældende fra 01.01.2008 (5979
dage). |
Historik | Start | Stop |
---|
Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 01.01.2008 | |
Forskning og udvikling inden for naturvidenskab og teknik (731000) | 01.01.1998 | 31.12.2007 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 23.04.1999 (9154
dage). |
Ingen historik.
Revisor | KPMG P/S |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 17.12.2014 (3437
dage). |
Historik | Start | Stop |
---|
horsholm.finance@roche.com | 07.07.2016 | 27.06.2022 |
christian.hansen@roche.com | 29.06.2016 | 06.07.2016 |
mail@santaris.com | 15.02.2004 | 28.06.2016 |
Ingen nuværende registrering.
Historik | Start | Stop |
---|
30307871 | 29.06.2016 | 07.07.2016 |
45179800 | 15.02.2004 | 28.06.2016 |
Ingen nuværende registrering.
Navne | RICC A/S. |
Sidst opdateret den 21.02.2024 og
angivet som gældende fra 21.02.2024 (84
dage). |
Historik | Start | Stop |
---|
RICC A/S | 21.02.2024 | |
ROCHE INNOVATION CENTER COPENHAGEN A/S | 24.09.2014 | 20.02.2024 |
SANTARIS PHARMA A/S | 19.05.2003 | 23.09.2014 |
PANTHECO A/S | 16.10.1998 | 18.05.2003 |
BIOTECHNOLOGY AF 24. SEPTEMBER 1998 ApS | 25.09.1998 | 15.10.1998 |
ApS KBIL 9 NR. 2067 | 01.01.1998 | 24.09.1998 |
Tegningsregel | Selskabet tegnes af et bestyrelsesmedlem i forening med et direktionsmedlem eller af to bestyrelsesmedlemmer i forening eller af to direktionsmedlemmer i forening. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 24.09.2014 (3521
dage). |
Fortolkning
(3 tegningsmuligheder)
| 1 bestyrelsesmedlem + 1 direktionsmedlem |
2 bestyrelsesmedlemmer + |
2 direktionsmedlemmer + |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMGStatsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State AuthorisedPublic Accountant
Virksomhedens regnskabsklasse:Reporting class C, medium-size enterprise
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standard on Auditing (ISAs) andthe additional requirements applicable in Denmark. Our responsibilities under thosestandards and requirements are further described in the "Auditor's responsibilities for theaudit of the financial statements" section of our report. We are independent of the Company in accordance with the International EthicsStandards Board for Accountants' International Code of Ethics for Professional Accountants(IESBA Code) and the additional ethical requirements applicable in Denmark, and wehave fulfilled our other ethical responsibilities in accordance with these requirements andthe IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate toprovide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Roche Innovation Center Copenhagen A/Sfor the financial year 1 January – 31 December 2022 comprising income statement,balance sheet, statement of changes in equity, and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial StatementsAct. In our opinion, the financial statements give a true and fair view of the Company's assets,liabilities and financial position at 31 December 2022 and of the results of the Company'soperations for the financial year 1 January – 31 December 2022 in accordance with theDanish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and wedo not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read theManagement's review and, in doing so, consider whether the Management's review ismaterially inconsistent with the financial statements or our knowledge obtained during theaudit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides theinformation required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is inaccordance with the financial statements and has been prepared in accordance with therequirements of the Danish Financial Statement Act. We did not identify any materialmisstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.